Related Experiment Videos
[Diagnosis and treatment of Wilms' tumor]
Insights
Wilms
Area of Science:
- Pediatric Oncology
- Nephrology
- Clinical Genetics
Background:
- Wilms' tumor, a common pediatric kidney cancer, requires precise diagnosis and effective treatment strategies.
- Understanding its clinical and pathological characteristics is crucial for improving patient outcomes.
Observation:
- Wilms' tumor predominantly affects children under five.
- Congenital anomalies are frequently observed alongside this nephroblastoma.
- Chromosome 11 short arm deletions are linked to tumor development.
- Distant metastases at diagnosis are uncommon.
- Distinguishing Wilms' tumor from neuroblastoma can be challenging.
- No specific tumor marker currently exists for Wilms' tumor.
Findings:
- The study reviews current advancements in Wilms' tumor diagnosis and treatment.
- Key clinical and pathological features have been identified.
- Current two-year survival rates approach 90%.
Implications:
- Improved diagnostic approaches are needed, especially for differentiating from neuroblastoma.
- Further research into specific tumor markers could enhance early detection.
- The high survival rate underscores the effectiveness of current management strategies for Wilms' tumor.
Abstract:
Recent advances in the diagnosis and treatment of Wilms' tumor are reviewed. Our study disclosed that principal clinical and pathological features of Wilms' tumor are as follows: (1) It occurs in young infants and children under 5 years of age; (2) It is frequently associated with other congenital anomalies; (3) Deletion of a portion of short arm of chromosome 11 can be closely related to the tumor genesis of nephroblastoma; (4) The occurrence of distant metastases is rare at diagnosis; (5) Differential diagnosis between Wilms' tumor and neuroblastoma is occasionally quite difficult; (6) There is no good tumor marker specific to Wilms' tumor; and (7) Two-year survival rate is about 90% at present.